女性のヘルステック市場レポート：2024-2034
Female Health Tech Market Report 2024-2034
レポート詳細
女性ヘルステック市場レポート 2024-2034年 ：本レポートは、業界とその根底にあるダイナミクスをよりよく理解することを望むなら、新たな収益ポケットを目指す大手企業にとって貴重な... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
女性ヘルステック市場レポート 2024-2034年：本レポートは、業界とその根底にあるダイナミクスをよりよく理解することを望むなら、新たな収益ポケットを目指す大手企業にとって貴重なものとなるでしょう。異業種への進出や新地域での既存事業の拡大を目指す企業にも有用です。
女性の健康に対する意識と関心の高まり
女性の健康に対する認識と注目の高まりは、女性特有のヘルスケアのニーズに長い間注目されてきた諸要因の合流によってもたらされた変革である。歴史的に、女性の健康問題はしばしば見過ごされたり、医療という広い文脈の中で一般化されたりしてきた。しかし、医療専門家、研究者、擁護団体、政策立案者の一致団結した努力により、このような状況は一変した。研究イニシアティブは、女性特有の病態を掘り下げ、生殖に関する健康、ホルモンの変動、子宮内膜症や多嚢胞性卵巣症候群（PCOS）などの病気の複雑さを解明してきた。同時に、教育キャンペーンは、女性の健康を取り巻くタブーを取り払い、開かれた対話を促進し、女性が自らの幸福を擁護できるようにすることを目指してきた。公衆衛生キャンペーンは、妊産婦死亡率、乳がんの認知度、避妊へのアクセスといった重要な問題にスポットライトを当て、的を絞った介入への緊急性を高めてきた。さらに、アドボカシー運動は政策変更を促し、女性の健康が公衆衛生課題の基本的な側面であるとの認識を高めることにつながった。このような意識の高まりは、ヘルスケアに対するより包括的なアプローチを促進しただけでなく、月経追跡のためのウェアラブルデバイスから、パーソナライズされた健康洞察のためのAIを搭載したプラットフォームまで、様々なソリューションによって、女性の健康テクノロジーにおけるイノベーションを推進した。全体として、女性の健康に対する認識と注目の高まりは、公平な医療提供への極めて重要なシフトと、生涯にわたる女性の多様なニーズへの深い理解を意味している。
患者ケアにおける技術の進歩
女性のヘルステックにおける技術の進歩は、女性特有のニーズや経験に対応した革新的なソリューションを提供し、女性のヘルスケアの展望を一変させた。これらの進歩は、リプロダクティブ・ヘルスから更年期管理まで幅広い分野に及び、様々な技術分野におけるブレークスルーによって可能となった。
スマートウォッチやフィットネストラッカーなどのウェアラブルデバイスは、女性が月経周期をモニターし、受胎可能期間を追跡し、全体的な健康とウェルネスを管理するための強力なツールとして登場した。これらのデバイスはセンサーとアルゴリズムを活用して生理的パラメーターのデータを収集し、ユーザーに生殖に関する健康についての貴重な洞察を提供し、避妊、受胎計画、月経周期の管理について十分な情報に基づいた決定を下すのに役立っている。
モバイルアプリケーションもまた、女性が自分の健康を管理する上で重要な役割を果たしている。これらのアプリは、月経追跡、排卵予測、妊娠モニタリング、子宮内膜症やPCOSなどの症状管理など、多様な機能を提供している。健康情報をデジタル化し、パーソナライズされたレコメンデーションを提供することで、これらのアプリは女性が自分の健康と幸福の管理に積極的に参加することを可能にする。
遠隔医療プラットフォームは、特に医療サービスが行き届いていない地域や移動に制約のある女性のヘルスケアサービスへのアクセスを拡大してきた。これらのプラットフォームは、医療提供者との遠隔相談を容易にし、女性が自宅にいながらにして助言を求めたり、診断を受けたり、治療にアクセスしたりすることを可能にする。COVID-19のパンデミックでは、対面での医療サービスが限られていたため、このプラットフォームが特に有用であることが証明された。
市場調査レポートを購入する前にすべき質問とは？
-
女性ヘルステック市場はどのように進化しているのか？
-
女性ヘルステック市場の推進要因と抑制要因は何か？
-
女性ヘルステックの各サブマーケットセグメントは予測期間中にどのように成長し、2034年にはどれくらいの収益を占めるようになるのか？
-
2024年から2034年にかけて、女性ヘルステックの各サブマーケットの市場シェアはどのように推移するのか？
-
2024年から2034年までの市場全体の主な牽引役は何か？
-
主要な女性ヘルステック市場はマクロ経済の動きに概ね追随するのか、それとも個々の国内市場が他を凌駕するのか？
-
2034年までに各国市場のシェアはどう変化し、2034年に市場をリードするのはどの地域か？
-
主要プレーヤーは誰で、予測期間中の見通しは？
-
これら主要企業の女性ヘルステック・プロジェクトとは？
-
2024年から2034年の間に、産業はどのように進化するのか？現在および今後実施される
-
健康テック・プロジェクトは現在、そして今後10年間にどのような意味を持つのか？
-
女性ヘルステック市場をさらに拡大するために、製品の商業化の必要性は高まっているか？
-
女性ヘルステック市場はどこに向かっているのか、また、どのようにすれば市場の最前線に立てるのか？
-
新製品や新サービスへの最適な投資方法とは？
-
企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？
このことが、女性のヘルステック市場に現在、そして今後10年間でどのような影響を与えるかを知る必要がある：
-
284ページに及ぶレポートには、101の表と130の図表が掲載されている。
-
このレポートでは、業界の主要な収益分野に焦点を当てているため、今すぐそこにターゲットを絞ることができます。
-
世界、地域、国の売上高と成長に関する詳細な分析が含まれている。
-
競合他社が成功した主なトレンド、変化、収益予測をハイライトします。
本レポートは、女性ヘルステック市場が今後10年間にどのように発展していくのか、またCOVID-19の景気後退と好転の変動に合わせてどのように発展していくのかを今でお伝えするものである。この市場は、過去10年間のどの時点よりも今が重要である。
2034年までの予測やその他の分析から、商業的な展望が明らかになる
-
2034年までの収益予測に加え、最近の実績、成長率、市場シェアも提供している。
-
ビジネスの展望や展開など、独自の分析が掲載されている。
-
定性的分析（市場ダイナミクス、促進要因、機会、阻害要因、課題を含む）、コスト構造、女性向けヘルステック価格上昇の影響、最近の動向をご覧いただけます。
本レポートには、COVID-19が業界と貴社にどのような影響を与えるかについてのデータ分析と貴重な洞察が含まれている。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じている。
レポート対象セグメント
製品タイプ別
-
消費者製品
-
デバイス（ウェアラブル、ハードウェア）
-
ソフトウェア（アプリ）
-
診断
-
デジタル・プラットフォーム
-
医薬品、ビタミン、サプリメント
-
サービス
-
テレヘルス
用途別
-
妊娠と看護
-
リプロダクティブ・ヘルスと避妊
-
月経の健康
-
ヘルスケア全般
-
骨盤と子宮のヘルスケア
-
性の健康
-
ウィメンズ・ウェルネス
-
更年期ケア
-
長寿
-
メンタルヘルス
世界市場全体とセグメント別の収益予測に加え、4つの地域と25の主要国市場の収益予測も掲載している：
北米
欧州
-
ドイツ
-
英国
-
フランス
-
スペイン
-
イタリア
-
ポーランド
-
ベルギー
-
その他の欧州
アジア太平洋
-
中国
-
日本
-
インド
-
オーストラリア
-
韓国
-
シンガポール
-
台湾
-
その他のアジア太平洋
ラテンアメリカ
-
ブラジル
-
メキシコ
-
アルゼンチン
-
その他のラテンアメリカ
MEA
本レポートには、2024年から2034年までの女性ヘルステック市場における主要企業のプロファイルも掲載されている。
主要企業と市場成長の可能性
-
Athena Feminine Technologies
-
Bloomlife
-
Elvie (Chiaro Technology Limited)
-
HeraMED
-
iSono Health
-
Minerva Surgical
-
NUVO Inc
-
Prelude Fertility, Inc.
-
Sera Prognostics
-
Univfy Inc.
-
TOTOHEALTH LIMITED
2024年から2034年までの女性ヘルスケア技術市場全体の世界売上高（金額ベース）は、2024年に1,409億米ドルを突破する。2034年まで力強い収益成長を予測している。当研究所では、最も大きな可能性を秘めた組織を特定しています。彼らの能力、進歩、商業的展望を発見し、あなたが一歩先を行くのを支援します。
女性ヘルステック市場、2024〜2034年」レポートはどのようにお役に立ちますか？
要約すると、280ページを超えるこのレポートは、以下の知識を提供する：
-
女性ヘルステック市場、2024年から2034年までの収益予測 素材、デザイン、タイプ、デリバリー、アプリケーションの各予測を世界および地域レベルで掲載 - 業界の将来性を発見し、投資と収益に最も有利な場所を見つけることができます。
-
5つの地域と27の主要国市場の2034年までの収益予測 - 北米、欧州、アジア太平洋、ラテンアメリカ、MEAの女性ヘルステック市場の2024年から2034年までの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの著名経済圏の市場も予測しています。
-
2024年から2034年までの女性ヘルステック市場に関わる主要企業11社の企業プロファイルを含む。
独自の予測による定量的・定性的分析をご覧ください。私たちのレポートだけに含まれる情報を入手し、貴重なビジネスインテリジェンスで情報を得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性が低くなります。私たちの研究が貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainのこの調査レポートは、2024年から2034年までの女性ヘルステック市場の商業分析を必要とするすべての人、市場をリードする企業を対象としています。データ、トレンド、予測をご覧いただけます。
ページTOPに戻る
目次
目次
1 レポート概要
1.1 研究の目的
1.2 女性ヘルステック市場の紹介
1.3 本レポートの内容
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ）
1.9 Visiongainの関連レポート
1.10 Visiongainについて
2 エグゼクティブ・サマリー
3 市場概要
3.1 主要な調査結果
3.2 市場ダイナミクス
3.2.1 市場促進要因
3.2.1.1 意識と教育の高まり
3.2.1.2 技術の急速な進歩が女性ヘルステック市場の成長を促進
3.2.1.3 女性の健康とウェルネスに対するエンパワーメントと支持の高まり
3.2.1.4 ヘルスケアのパーソナライゼーションが女性向けヘルステック市場の成長の原動力
3.2.2 市場阻害要因
3.2.2.1 複雑な規制の枠組みと地域によって異なる医療技術の基準
3.2.2.2 機密性の高い健康データの収集、保存、送信に伴うプライバシーとセキュリティのリスク
3.2.2.3 特に医療サービスが行き届いていない地域や社会的に疎外されたコミュニティにおける医療不公平と医療サービスへのアクセス格差
3.2.3 市場機会
3.2.3.1 女性の健康に関するアンメット・ニーズに対応する新しい製品・サービスの開発
3.2.3.2 医療提供者、テクノロジー企業、研究機関のパートナーシップ
3.2.3.3 女性の健康アウトカムの改善を目指したグローバルヘルスイニシアティブ
3.3 COVID-19インパクト分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの交渉力
3.4.2 買い手の交渉力
3.4.3 競争相手のライバル関係
3.4.4 代替品による脅威
3.4.5 新規参入企業の脅威
3.5 PEST分析
4 女性ヘルステック市場分析：製品タイプ別
4.1 主要な調査結果
4.2 アプリケーション・セグメント 市場魅力度指数
4.3 女性ヘルステック製品タイプ別市場規模推定と予測
4.4 消費者向け製品
4.4.1 2024〜2034年の地域別市場規模（US$ Billion）
4.4.2 地域別市場シェア、2024年・2034年(%)
4.5 デバイス（ウェアラブル、ハードウェア）
4.5.1 2024〜2034年の地域別市場規模（US$ Billion）
4.5.2 地域別市場シェア、2024年・2034年(%)
4.6 ソフトウェア（アプリ）
4.6.1 2024〜2034年の地域別市場規模（US$ Billion）
4.6.2 地域別市場シェア、2024年・2034年(%)
4.7 診断薬
4.7.1 2024〜2034年の地域別市場規模（US$ Billion）
4.7.2 地域別市場シェア、2024年・2034年(%)
4.8 デジタルプラットフォーム
4.8.1 2024〜2034年の地域別市場規模（US$ Billion）
4.8.2 地域別市場シェア、2024年・2034年(%)
4.9 医薬品、ビタミン、サプリメント
4.9.1 2024〜2034年の地域別市場規模（US$ Billion）
4.9.2 地域別市場シェア、2024年・2034年(%)
4.10 サービス
4.10.1 2024〜2034年の地域別市場規模（US$ Billion）
4.10.2 地域別市場シェア、2024年・2034年(%)
4.11 テレヘルス
4.11.1 2024〜2034年の地域別市場規模（US$ Billion）
4.11.2 地域別市場シェア、2024年・2034年(%)
5 女性ヘルステック市場分析：用途別
5.1 主な調査結果
5.2 用途別セグメント 市場魅力度指数
5.3 女性ヘルステック市場用途別市場規模推定と予測
5.4 妊娠と介護
5.4.1 2024〜2034年の地域別市場規模（US$ Billion）
5.4.2 地域別市場シェア、2024年・2034年(%)
5.5 リプロダクティブヘルスと避妊
5.5.1 2024〜2034年の地域別市場規模（US$ Billion）
5.5.2 地域別市場シェア、2024年・2034年(%)
5.6 生理の健康
5.6.1 2024〜2034年の地域別市場規模（US$ Billion）
5.6.2 地域別市場シェア、2024年・2034年(%)
5.7 一般ヘルスケア
5.7.1 2024〜2034年の地域別市場規模（US$ Billion）
5.7.2 地域別市場シェア、2024年・2034年(%)
5.8 骨盤・子宮ヘルスケア
5.8.1 2024〜2034年の地域別市場規模（US$ Billion）
5.8.2 地域別市場シェア、2024年・2034年(%)
5.9 性的健康
5.9.1 2024〜2034年の地域別市場規模（US$ Billion）
5.9.2 地域別市場シェア、2024年・2034年(%)
5.10 女性ウェルネス
5.10.1 2024〜2034年の地域別市場規模（US$ Billion）
5.10.2 地域別市場シェア、2024年・2034年(%)
5.11 更年期ケア
5.11.1 2024〜2034年の地域別市場規模（US$ Billion）
5.11.2 地域別市場シェア、2024年・2034年(%)
5.12 長寿
5.12.1 2024〜2034年の地域別市場規模（US$ Billion）
5.12.2 地域別市場シェア、2024年・2034年(%)
5.13 メンタルヘルス
5.13.1 2024〜2034年の地域別市場規模（US$ Billion）
5.13.2 地域別市場シェア、2024年・2034年(%)
6 女性ヘルステック市場分析：地域別
6.1 主要な調査結果
6.2 地域別市場規模の推定と予測
7 北米の女性ヘルステック市場分析
7.1 主要な調査結果
7.2 北米の女性ヘルステック市場魅力度指数
7.3 北米の女性ヘルステック国別市場、2024年、2029年、2034年（US$ Billion）
7.4 北米の女性ヘルステック市場規模推定と予測：国別
7.5 北米の女性ヘルステック市場規模推定と予測：製品タイプ別
7.6 北米の女性ヘルステック市場規模推定と予測：用途別
7.7 アメリカの女性ヘルステック市場分析
7.8 カナダの女性ヘルステック市場分析
8 欧州の女性ヘルステック市場分析
8.1 主要な調査結果
8.2 欧州の女性ヘルステック市場魅力度指数
8.3 欧州の女性ヘルステック国別市場、2024年、2029年、2034年（US$ Billion）
8.4 欧州の女性ヘルステック市場規模推定と予測：国別
8.5 欧州の女性ヘルステック市場規模推定と予測：製品タイプ別
8.6 欧州の女性ヘルステック市場規模推定と予測：用途別
8.7 ドイツの女性ヘルステック市場分析
8.8 フランスの女性ヘルステック市場分析
8.9 イギリスの女性ヘルステック市場分析
8.10 イタリアの女性ヘルステック市場分析
8.11 スペインの女性ヘルステック市場分析
8.12 ロシアの女性ヘルステック市場分析
8.13 ポーランドの女性ヘルステック市場分析
8.14 ベルギーの女性ヘルステック市場分析
8.15 その他の欧州の女性ヘルステック市場分析
9 アジア太平洋地域の女性ヘルステック市場分析
9.1 主要な調査結果
9.2 アジア太平洋地域の女性ヘルステック市場魅力度指数
9.3 アジア太平洋地域の女性ヘルステック国別市場、2024年、2029年、2034年（US$ Billion）
9.4 アジア太平洋地域の女性ヘルステック市場規模推定と予測：国別
9.5 アジア太平洋地域の女性ヘルステック市場規模推定と予測：製品タイプ別
9.6 アジア太平洋地域の女性ヘルステック市場規模推定と予測：用途別
9.7 日本の女性ヘルステック市場分析
9.8 中国の女性ヘルステック市場分析
9.9 インドの女性ヘルステック市場分析
9.10 オーストラリアの女性ヘルステック市場分析
9.11 韓国の女性ヘルステック市場分析
9.12 シンガポールの女性ヘルステック市場分析
9.13 台湾の女性ヘルステック市場分析
9.14 その他のアジア太平洋地域の女性ヘルステック市場分析
10 ラテンアメリカの女性ヘルステック市場分析
10.1 主要調査結果
10.2 ラテンアメリカの女性ヘルステック市場魅力度指数
10.3 ラテンアメリカの女性ヘルステック国別市場、2024年、2029年、2034年（US$ Billion）
10.4 ラテンアメリカの女性ヘルステック市場規模推定と予測：国別
10.5 ラテンアメリカの女性ヘルステック市場規模推定と予測：製品タイプ別
10.6 ラテンアメリカの女性ヘルステック市場規模推定と予測：用途別
10.7 ブラジルの女性ヘルステック市場分析
10.8 メキシコの女性ヘルステック市場分析
10.9 アルゼンチンの女性ヘルステック市場分析
10.10 コロンビアの女性ヘルステック市場分析
10.11 その他のラテンアメリカの女性ヘルステック市場分析
11 MEAの女性ヘルステック市場分析
11.1 主要な調査結果
11.2 MEA女性ヘルステック市場魅力度指数
11.3 MEAの女性ヘルステック国別市場、2024年、2029年、2034年（US$ Billion）
11.4 MEAの女性ヘルステック市場規模推定と予測：国別
11.5 MEAの女性ヘルステック市場規模推定と予測：製品タイプ別
11.6 MEAの女性ヘルステック市場規模推定と予測：用途別
11.7 GCCの女性ヘルステック市場分析
11.8 南アフリカの女性ヘルステック市場分析
11.9 その他のMEA女性ヘルステック市場分析
12 企業プロフィール
12.1 競争環境、2022年
12.2 戦略的展望のまとめ
12.3 Athena Feminine Technologies, Inc.
12.3.1 会社概要
12.3.2 会社概要
12.3.3 製品ベンチマーク
12.3.4 戦略的展望
12.4 Bloomlife, Inc.
12.4.1 会社概要
12.4.2 会社概要
12.4.3 製品ベンチマーク
12.4.4 戦略的展望
12.5 Elvie (Chiaro Technology Limited)
12.5.1 会社概要
12.5.2 会社概要
12.5.3 製品ベンチマーク
12.5.4 戦略的展望
12.6 HeraMed Ltd
12.6.1 会社概要
12.6.2 会社概要
12.6.3 財務分析
12.6.3.1 純収入、2018-2022年
12.6.3.2 R＆D、2017-2022年
12.6.4 製品ベンチマーク
12.6.5 戦略的展望
12.7 iSono Health, Inc.
12.7.1 会社概要
12.7.2 会社概要
12.7.3 製品ベンチマーク
12.7.4 戦略的展望
12.8 Minerva Surgical, Inc.
12.8.1 会社概要
12.8.2 会社概要
12.8.3 財務分析
12.8.3.1 純収入、2020-2022年
12.8.3.2 売上高、2020-2022年
12.8.4 製品ベンチマーク
12.8.5 戦略的展望
12.9 Nuvo, Inc.
12.9.1 会社概要
12.9.2 会社概要
12.9.3 製品ベンチマーク
12.9.4 戦略的展望
12.10 Prelude Fertility, Inc.
12.10.1 会社概要
12.10.2 会社概要
12.10.3 製品ベンチマーク
12.10.4 戦略的展望
12.11 Sera Prognostics
12.11.1 会社概要
12.11.2 会社概要
12.11.3 財務分析
12.11.3.1 純収入、2017-2022年
12.11.3.2 売上高、2017-2022年
12.11.4 製品ベンチマーク
12.11.5 戦略的展望
12.12 Univfy, Inc.
12.12.1 会社概要
12.12.2 会社概要
12.12.3 製品ベンチマーク
12.12.4 戦略的展望
12.13 Totohealth Limited
12.13.1 会社概要
12.13.2 会社概要
12.13.3 製品ベンチマーク
13 結論と提言
13.1 Visiongainからの結びの言葉
13.2 市場プレイヤーへの提言
ページTOPに戻る
図表リスト
表の一覧
Table 1 Female Health Tech Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 7 Consumer Products Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 8 Devices (Wearables, hardware) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 9 Software (Apps) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Diagnostics Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Digital Platform Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Drugs, Vitamins & Supplements Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Telehealth Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 16 Pregnancy and Nursing Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 17 Reproductive Health and Contraception Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 18 Menstrual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 General Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Pelvic and Uterine Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Sexual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Women’s Wellness Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Menopause Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Longevity Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Mental Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 North America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 28 North America Female Health Tech Market Product Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 29 North America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 30 U.S. Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 Canada Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 32 Europe Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Europe Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 34 Europe Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 35 Germany Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 36 France Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 37 UK Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 Italy Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 39 Spain Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 Russia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Poland Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Belgium Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Rest of Europe Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 44 Asia Pacific Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 Asia Pacific Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 46 Asia Pacific Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 47 Japan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 48 China Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 India Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 50 Australia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 51 South Korea Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Singapore Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Taiwan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Rest of Asia Pacific Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Latin America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Latin America Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 57 Latin America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 58 Brazil Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 59 Mexico Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Argentina Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 Colombia Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 Rest of Latin America Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 63 MEA Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 MEA Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 65 MEA Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 66 GCC Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 South Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 Rest of MEA Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 69 Strategic Outlook
Table 70 Athena Feminine Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 Athena Feminine Technologies, Inc.: Product Benchmarking
Table 72 Athena Feminine Technologies, Inc.: Strategic Outlook
Table 73 Bloomlife, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Bloomlife, Inc.: Product Benchmarking
Table 75 Bloomlife, Inc.: Strategic Outlook
Table 76 Elvie (Chiaro Technology Limited) : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Elvie (Chiaro Technology Limited): Product Benchmarking
Table 78 Elvie (Chiaro Technology Limited): Strategic Outlook
Table 79 HeraMed Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 HeraMed Ltd: Product Benchmarking
Table 81 HeraMed Ltd.: Strategic Outlook
Table 82 iSono Health, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 iSono Health, Inc.: Product Benchmarking
Table 84 iSono Health, Inc.: Strategic Outlook
Table 85 Minerva Surgical, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Minerva Surgical, Inc.: Product Benchmarking
Table 87 Minerva Surgical, Inc.: Strategic Outlook
Table 88 Nuvo, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Nuvo, Inc.: Product Benchmarking
Table 90 Nuvo, Inc.: Strategic Outlook
Table 91 Prelude Fertility, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Prelude Fertility, Inc.: Product Benchmarking
Table 93 Prelude Fertility, Inc.: Strategic Outlook
Table 94 Sera Prognostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Sera Prognostics: Product Benchmarking
Table 96 Sera Prognostics: Strategic Outlook
Table 97 Univfy, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Univfy Inc.: Product Benchmarking
Table 99 Univfy Inc.: Strategic Outlook
Table 100 Totohealth Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Totohealth Limited.: Product Benchmarking
図の一覧
Figure 1 Female Health Tech Market Segmentation
Figure 2 Female Health Tech Market by Product: Market Attractiveness Index
Figure 3 Female Health Tech Market by Application: Market Attractiveness Index
Figure 4 Female Health Tech Market Attractiveness Index by Region
Figure 5 Female Health Tech Market: Market Dynamics
Figure 6 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 7 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 8 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 9 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 10 Female Health Tech Market: Porter’s Five Forces Analysis
Figure 11 Female Health Tech Market: PEST Analysis
Figure 12 Female Health Tech Market by Product Types: Market Attractiveness Index
Figure 13 Female Health Tech Market Forecast by Product Types, 2024-2034 (US$ Billion, AGR %)
Figure 14 Female Health Tech Market Share Forecast by Product Types, 2024, 2029, 2034 (%)
Figure 15 Consumer Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 16 Consumer Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 17 Devices (Wearables, hardware) Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 18 Devices (Wearables, hardware) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Software (Apps) Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 20 Software (Apps) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Diagnostics Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 22 Diagnostics Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Digital Platform Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 24 Digital Platform Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Drugs, Vitamins & Supplements Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 26 Drugs, Vitamins & Supplements Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 28 Services Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Telehealth Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 30 Telehealth Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Female Health Tech Market by Application: Market Attractiveness Index
Figure 32 Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 33 Female Health Tech Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 34 Pregnancy and Nursing Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 35 Pregnancy and Nursing Care Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Reproductive Health and Contraception Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 37 Reproductive Health and Contraception Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Menstrual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 39 Menstrual Health Market Share Forecast by Region, 2024 & 2034 (%)
Figure 40 General Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 41 General Healthcare Market Share Forecast by Region, 2024 & 2034 (%)
Figure 42 Pelvic and Uterine Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 43 Pelvic and Uterine Healthcare Market Share Forecast by Region, 2024 & 2034 (%)
Figure 44 Sexual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 45 Sexual Health Market Share Forecast by Region, 2024 & 2034 (%)
Figure 46 Women’s Wellness Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 47 Women’s Wellness Market Share Forecast by Region, 2024 & 2034 (%)
Figure 48 Menopause Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 49 Menopause Care Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Longevity Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 51 Longevity Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 Mental Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 53 Mental Health Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Female Health Tech Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
Figure 55 Female Health Tech Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 56 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 57 North America Female Health Tech Market Attractiveness Index
Figure 58 North America Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 59 North America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 60 North America Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 61 North America Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 62 North America Female Health Tech Market Share Forecast by Type, 2024 & 2034 (%)
Figure 63 North America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 64 North America Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 65 U.S. Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 66 Canada Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 67 Europe Female Health Tech Market Attractiveness Index
Figure 68 Europe Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 69 Europe Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 70 Europe Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 71 Europe Female Health Tech Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 72 Europe Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 73 Europe Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 74 Europe Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 75 Germany Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 76 France Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 77 UK Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 78 Italy Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 79 Spain Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 80 Russia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 81 Poland Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 82 Belgium Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 83 Rest of Europe Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 84 Asia Pacific Female Health Tech Market Attractiveness Index
Figure 85 Asia Pacific Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 86 Asia Pacific Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 87 Asia Pacific Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 88 Asia Pacific Female Health Tech Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 89 Asia Pacific Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 90 Asia Pacific Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 91 Asia Pacific Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 92 Japan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 93 China Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 94 India Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 95 Australia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 96 South Korea Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 97 Singapore Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 98 Taiwan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 99 Rest of Asia Pacific Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 100 Latin America Female Health Tech Market Attractiveness Index
Figure 101 Latin America Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 102 Latin America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 103 Latin America Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 104 Latin America Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 105 Latin America Female Health Tech Market Share Forecast by Type, 2024 & 2034 (%)
Figure 106 Latin America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 107 Latin America Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 108 Brazil Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 109 Mexico Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 110 Argentina Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 111 Colombia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 112 Rest of Latin America Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 113 MEA Female Health Tech Market Attractiveness Index
Figure 114 MEA Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 115 MEA Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 116 MEA Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 117 MEA Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 118 MEA Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 119 MEA Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 120 MEA Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 121 GCC Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 122 South Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 123 Rest of MEA Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 124 Female Health Tech Company Share, 2022
Figure 125 HeraMed Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 126 HeraMed Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 127 Minerva Surgical, Inc.: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 128 Minerva Surgical, Inc.: R&D, 2020-2022 (US$ Million, AGR%)
Figure 129 Sera Prognostics: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 130 Sera Prognostics: R&D, 2017-2022 (US$ Million, AGR%)
ページTOPに戻る
Summary
Report Details
The Female Health Tech Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increased Awareness and Focus on Women’s Health
Increased awareness and focus on women’s health have been transformative, driven by a confluence of factors that have brought long-overdue attention to the unique healthcare needs of women. Historically, women’s health issues were often overlooked or generalized within the broader context of healthcare. However, concerted efforts from healthcare professionals, researchers, advocacy groups, and policymakers have reshaped this landscape. Research initiatives have delved into conditions specific to women, unravelling the complexities of reproductive health, hormonal fluctuations, and diseases like endometriosis and polycystic ovary syndrome (PCOS). Simultaneously, educational campaigns have sought to dismantle taboos surrounding women’s health, fostering open dialogues and empowering women to advocate for their own well-being. Public health campaigns have spotlighted critical issues such as maternal mortality rates, breast cancer awareness, and access to contraception, amplifying the urgency for targeted interventions. Moreover, advocacy movements have catalyzed policy changes, leading to greater recognition of women’s health as a fundamental aspect of public health agendas. This heightened awareness has not only fostered a more inclusive approach to healthcare but has also driven innovation in female health technology, with solutions ranging from wearable devices for menstrual tracking to AI-powered platforms for personalized health insights. Overall, the increased awareness and focus on women’s health signify a pivotal shift towards equitable healthcare provision and a deeper understanding of the diverse needs of women across the lifespan.
Technological advancements in patient care
Technological advancements in female health tech have revolutionized the landscape of women’s healthcare, offering innovative solutions tailored to address the unique needs and experiences of women. These advancements span a wide range of areas, from reproductive health to menopause management, and have been made possible by breakthroughs in various fields of technology.
Wearable devices, such as smartwatches and fitness trackers, have emerged as powerful tools for women to monitor their menstrual cycles, track fertility windows, and manage overall health and wellness. These devices leverage sensors and algorithms to collect data on physiological parameters, providing users with valuable insights into their reproductive health and helping them make informed decisions about contraception, fertility planning, and menstrual cycle management.
Mobile applications have also played a crucial role in empowering women to take control of their health. These apps offer a diverse array of features, including menstrual tracking, ovulation prediction, pregnancy monitoring, and symptom management for conditions like endometriosis and PCOS. By digitizing health information and providing personalized recommendations, these apps enable women to actively participate in managing their health and well-being.
Telemedicine platforms have expanded access to healthcare services for women, particularly in underserved areas or for individuals with mobility constraints. These platforms facilitate remote consultations with healthcare providers, enabling women to seek advice, receive diagnoses, and access treatments from the comfort of their homes. This has proven especially valuable during the COVID-19 pandemic, when in-person healthcare services were limited.
What Questions Should You Ask before Buying a Market Research Report?
-
How is the Female Health Tech Market evolving?
-
What is driving and restraining the Female Health Tech Market?
-
How will each Female Health Tech submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
-
How will the market shares for each Female Health Tech submarket develop from 2024 to 2034?
-
What will be the main driver for the overall market from 2024 to 2034?
-
Will leading Female Health Tech Markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
-
How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
-
Who are the leading players and what are their prospects over the forecast period?
-
What are the Female Health Tech projects for these leading companies?
-
How will the industry evolve during the period between 2024 and 2034? What are the implications of Female Health
-
Tech projects taking place now and over the next 10 years?
-
Is there a greater need for product commercialisation to further scale the Female Health Tech Market?
-
Where is the Female Health Tech Market heading and how can you ensure you are at the forefront of the market?
-
What are the best investment options for new product and service lines?
-
What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Female Health Tech Market today, and over the next 10 years:
-
Our 284-page report provides 101 tables and 130 charts/graphs exclusively to you.
-
The report highlights key lucrative areas in the industry so you can target them – NOW.
-
It contains in-depth analysis of global, regional and national sales and growth.
-
It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Female Health Tech Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
-
In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
-
You will find original analyses, with business outlooks and developments.
-
Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Female Health Tech prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
By Product Types
-
Consumer Products
-
Devices (Wearables, Hardware)
-
Software (Apps)
-
Diagnostics
-
Digital Platform
-
Drugs, Vitamins & Supplements
-
Services
-
Telehealth
By Application
-
Pregnancy and Nursing Care
-
Reproductive Health and Contraception
-
Menstrual Health
-
General Healthcare
-
Pelvic and Uterine Healthcare
-
Sexual Health
-
Women’s Wellness
-
Menopause Care
-
Longevity
-
Mental Health
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 25 leading national markets:
North America
Europe
-
Germany
-
UK
-
France
-
Spain
-
Italy
-
Poland
-
Belgium
-
Rest of Europe
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Singapore
-
Taiwan
-
Rest of Asia Pacific
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Rest of Latin America
MEA
-
GCC
-
South Africa
-
Rest of MEA
The report also includes profiles and for some of the leading companies in the Female Health Tech Market, 2024 to 2034, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
-
Athena Feminine Technologies
-
Bloomlife
-
Elvie (Chiaro Technology Limited)
-
HeraMED
-
iSono Health
-
Minerva Surgical
-
NUVO Inc
-
Prelude Fertility, Inc.
-
Sera Prognostics
-
Univfy Inc.
-
TOTOHEALTH LIMITED
Overall world revenue for Female Health Tech Market, 2024 to 2034 in terms of value the market will surpass US$ 140.9 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Female Health Tech Market, 2024 to 2034 report help you?
In summary, our 280+ page report provides you with the following knowledge:
-
Revenue forecasts to 2034 for Female Health Tech Market, 2024 to 2034 Market, with forecasts for material, design, type, delivery and application, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
-
Revenue forecasts to 2034 for five regional and 27 key national markets – See forecasts for the Female Health Tech Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
-
Prospects for established firms and those seeking to enter the market – including company profiles for 11 of the major companies involved in the Female Health Tech Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Female Health Tech Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Female Health Tech Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Awareness and Education
3.2.1.2 Rapid Advancements in Technology are Catalysing the Growth of the Female Health Tech Market
3.2.1.3 Increasing Empowerment and Advocacy for Women's Health and Wellness
3.2.1.4 Healthcare Personalization is a Key Driving Force Behind the Growth of the Female Health Tech
3.2.2 Market Restraining Factors
3.2.2.1 Complex Regulatory Frameworks and Varying Standards for Healthcare Technologies Across Different Region
3.2.2.2 Privacy and Security Risks Associated with the Collection, Storage, and Transmission of Sensitive Health Data
3.2.2.3 Healthcare Inequities and Disparities in Access to Healthcare Services, Particularly in Underserved Regions and Marginalized Communities
3.2.3 Market Opportunities
3.2.3.1 Development of New Products and Services that Address Unmet Needs in Women's Health
3.2.3.2 Partnerships Between Healthcare Providers, Technology Companies, and Research Institutions
3.2.3.3 Global Health Initiatives Aimed at Improving Women's Health Outcomes
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Female Health Tech Market Analysis by Product Type
4.1 Key Findings
4.2 Application Segment: Market Attractiveness Index
4.3 Female Health Tech Market Size Estimation and Forecast by Product Types
4.4 Consumer Products
4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
4.4.2 Market Share by Region, 2024 & 2034 (%)
4.5 Devices (Wearables, hardware)
4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
4.5.2 Market Share by Region, 2024 & 2034 (%)
4.6 Software (Apps)
4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
4.6.2 Market Share by Region, 2024 & 2034 (%)
4.7 Diagnostics
4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
4.7.2 Market Share by Region, 2024 & 2034 (%)
4.8 Digital Platform
4.8.1 Market Size by Region, 2024-2034 (US$ Billion)
4.8.2 Market Share by Region, 2024 & 2034 (%)
4.9 Drugs, Vitamins & Supplements
4.9.1 Market Size by Region, 2024-2034 (US$ Billion)
4.9.2 Market Share by Region, 2024 & 2034 (%)
4.10 Services
4.10.1 Market Size by Region, 2024-2034 (US$ Billion)
4.10.2 Market Share by Region, 2024 & 2034 (%)
4.11 Telehealth
4.11.1 Market Size by Region, 2024-2034 (US$ Billion)
4.11.2 Market Share by Region, 2024 & 2034 (%)
5 Female Health Tech Market Analysis by Application
5.1 Key Findings
5.2 Application Segment: Market Attractiveness Index
5.3 Female Health Tech Market Size Estimation and Forecast by Application
5.4 Pregnancy and Nursing Care
5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
5.4.2 Market Share by Region, 2024 & 2034 (%)
5.5 Reproductive Health and Contraception
5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
5.5.2 Market Share by Region, 2024 & 2034 (%)
5.6 Menstrual Health
5.6.1 Market Size by Region, 2024-2034 (US$ Billion)
5.6.2 Market Share by Region, 2024 & 2034 (%)
5.7 General Healthcare
5.7.1 Market Size by Region, 2024-2034 (US$ Billion)
5.7.2 Market Share by Region, 2024 & 2034 (%)
5.8 Pelvic and Uterine Healthcare
5.8.1 Market Size by Region, 2024-2034 (US$ Billion)
5.8.2 Market Share by Region, 2024 & 2034 (%)
5.9 Sexual Health
5.9.1 Market Size by Region, 2024-2034 (US$ Billion)
5.9.2 Market Share by Region, 2024 & 2034 (%)
5.10 Women’s Wellness
5.10.1 Market Size by Region, 2024-2034 (US$ Billion)
5.10.2 Market Share by Region, 2024 & 2034 (%)
5.11 Menopause Care
5.11.1 Market Size by Region, 2024-2034 (US$ Billion)
5.11.2 Market Share by Region, 2024 & 2034 (%)
5.12 Longevity
5.12.1 Market Size by Region, 2024-2034 (US$ Billion)
5.12.2 Market Share by Region, 2024 & 2034 (%)
5.13 Mental Health
5.13.1 Market Size by Region, 2024-2034 (US$ Billion)
5.13.2 Market Share by Region, 2024 & 2034 (%)
6 Female Health Tech Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Female Health Tech Market Analysis
7.1 Key Findings
7.2 North America Female Health Tech Market Attractiveness Index
7.3 North America Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
7.4 North America Female Health Tech Market Size Estimation and Forecast by Country
7.5 North America Female Health Tech Market Size Estimation and Forecast by Product Type
7.6 North America Female Health Tech Market Size Estimation and Forecast by Application
7.7 U.S. Female Health Tech Market Analysis
7.8 Canada Female Health Tech Market Analysis
8 Europe Female Health Tech Market Analysis
8.1 Key Findings
8.2 Europe Female Health Tech Market Attractiveness Index
8.3 Europe Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
8.4 Europe Female Health Tech Market Size Estimation and Forecast by Country
8.5 Europe Female Health Tech Market Size Estimation and Forecast by Product Type
8.6 Europe Female Health Tech Market Size Estimation and Forecast by Application
8.7 Germany Female Health Tech Market Analysis
8.8 France Female Health Tech Market Analysis
8.9 UK Female Health Tech Market Analysis
8.10 Italy Female Health Tech Market Analysis
8.11 Spain Female Health Tech Market Analysis
8.12 Russia Female Health Tech Market Analysis
8.13 Poland Female Health Tech Market Analysis
8.14 Belgium Female Health Tech Market Analysis
8.15 Rest of Europe Female Health Tech Market Analysis
9 Asia Pacific Female Health Tech Market Analysis
9.1 Key Findings
9.2 Asia Pacific Female Health Tech Market Attractiveness Index
9.3 Asia Pacific Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
9.4 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Country
9.5 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Product Type
9.6 Asia Pacific Female Health Tech Market Size Estimation and Forecast by Application
9.7 Japan Female Health Tech Market Analysis
9.8 China Female Health Tech Market Analysis
9.9 India Female Health Tech Market Analysis
9.10 Australia Female Health Tech Market Analysis
9.11 South Korea Female Health Tech Market Analysis
9.12 Singapore Female Health Tech Market Analysis
9.13 Taiwan Female Health Tech Market Analysis
9.14 Rest of Asia Pacific Female Health Tech Market Analysis
10 Latin America Female Health Tech Market Analysis
10.1 Key Findings
10.2 Latin America Female Health Tech Market Attractiveness Index
10.3 Latin America Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
10.4 Latin America Female Health Tech Market Size Estimation and Forecast by Country
10.5 Latin America Female Health Tech Market Size Estimation and Forecast by Product Type
10.6 Latin America Female Health Tech Market Size Estimation and Forecast by Application
10.7 Brazil Female Health Tech Market Analysis
10.8 Mexico Female Health Tech Market Analysis
10.9 Argentina Female Health Tech Market Analysis
10.10 Colombia Female Health Tech Market Analysis
10.11 Rest of Latin America Female Health Tech Market Analysis
11 MEA Female Health Tech Market Analysis
11.1 Key Findings
11.2 MEA Female Health Tech Market Attractiveness Index
11.3 MEA Female Health Tech Market by Country, 2024, 2029 & 2034 (US$ Billion)
11.4 MEA Female Health Tech Market Size Estimation and Forecast by Country
11.5 MEA Female Health Tech Market Size Estimation and Forecast by Product Type
11.6 MEA Female Health Tech Market Size Estimation and Forecast by Application
11.7 GCC Female Health Tech Market Analysis
11.8 South Africa Female Health Tech Market Analysis
11.9 Rest of MEA Female Health Tech Market Analysis
12 Company Profiles
12.1 Competitive Landscape, 2022
12.2 Summary of all Strategic Outlook
12.3 Athena Feminine Technologies, Inc.
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Product Benchmarking
12.3.4 Strategic Outlook
12.4 Bloomlife, Inc.
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Product Benchmarking
12.4.4 Strategic Outlook
12.5 Elvie (Chiaro Technology Limited)
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Product Benchmarking
12.5.4 Strategic Outlook
12.6 HeraMed Ltd
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2018-2022
12.6.3.2 R&D, 2017-2022
12.6.4 Product Benchmarking
12.6.5 Strategic Outlook
12.7 iSono Health, Inc.
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Product Benchmarking
12.7.4 Strategic Outlook
12.8 Minerva Surgical, Inc.
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2020-2022
12.8.3.2 R&D, 2020-2022
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Nuvo, Inc.
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Product Benchmarking
12.9.4 Strategic Outlook
12.10 Prelude Fertility, Inc.
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Product Benchmarking
12.10.4 Strategic Outlook
12.11 Sera Prognostics
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2022
12.11.3.2 R&D, 2017-2022
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Univfy, Inc.
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Product Benchmarking
12.12.4 Strategic Outlook
12.13 Totohealth Limited
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Product Benchmarking
13 Conclusion and Recommendations
13.1 Concluding Remarks from Visiongain
13.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 Female Health Tech Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
Table 2 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “W” Shaped Recovery
Table 5 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 6 Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 7 Consumer Products Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 8 Devices (Wearables, hardware) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 9 Software (Apps) Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 10 Diagnostics Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 11 Digital Platform Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 12 Drugs, Vitamins & Supplements Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 13 Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 14 Telehealth Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 15 Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 16 Pregnancy and Nursing Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 17 Reproductive Health and Contraception Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 18 Menstrual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 19 General Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 20 Pelvic and Uterine Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 21 Sexual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 22 Women’s Wellness Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 23 Menopause Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 24 Longevity Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 25 Mental Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 26 Female Health Tech Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 27 North America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 28 North America Female Health Tech Market Product Type, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 29 North America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 30 U.S. Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 31 Canada Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 32 Europe Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 33 Europe Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 34 Europe Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 35 Germany Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 36 France Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 37 UK Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 38 Italy Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 39 Spain Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 40 Russia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 41 Poland Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 42 Belgium Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 43 Rest of Europe Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 44 Asia Pacific Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 45 Asia Pacific Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 46 Asia Pacific Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 47 Japan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 48 China Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 49 India Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 50 Australia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 51 South Korea Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 52 Singapore Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 53 Taiwan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 54 Rest of Asia Pacific Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 55 Latin America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 56 Latin America Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 57 Latin America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 58 Brazil Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 59 Mexico Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 60 Argentina Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 61 Colombia Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 62 Rest of Latin America Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 63 MEA Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 64 MEA Female Health Tech Market Product Types, 2024-2034 (US$ Million, AGR%, CAGR%)
Table 65 MEA Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 66 GCC Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 67 South Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
Table 68 Rest of MEA Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR %)
Table 69 Strategic Outlook
Table 70 Athena Feminine Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 Athena Feminine Technologies, Inc.: Product Benchmarking
Table 72 Athena Feminine Technologies, Inc.: Strategic Outlook
Table 73 Bloomlife, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Bloomlife, Inc.: Product Benchmarking
Table 75 Bloomlife, Inc.: Strategic Outlook
Table 76 Elvie (Chiaro Technology Limited) : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Elvie (Chiaro Technology Limited): Product Benchmarking
Table 78 Elvie (Chiaro Technology Limited): Strategic Outlook
Table 79 HeraMed Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 HeraMed Ltd: Product Benchmarking
Table 81 HeraMed Ltd.: Strategic Outlook
Table 82 iSono Health, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 iSono Health, Inc.: Product Benchmarking
Table 84 iSono Health, Inc.: Strategic Outlook
Table 85 Minerva Surgical, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Minerva Surgical, Inc.: Product Benchmarking
Table 87 Minerva Surgical, Inc.: Strategic Outlook
Table 88 Nuvo, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Nuvo, Inc.: Product Benchmarking
Table 90 Nuvo, Inc.: Strategic Outlook
Table 91 Prelude Fertility, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Prelude Fertility, Inc.: Product Benchmarking
Table 93 Prelude Fertility, Inc.: Strategic Outlook
Table 94 Sera Prognostics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Sera Prognostics: Product Benchmarking
Table 96 Sera Prognostics: Strategic Outlook
Table 97 Univfy, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Univfy Inc.: Product Benchmarking
Table 99 Univfy Inc.: Strategic Outlook
Table 100 Totohealth Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Totohealth Limited.: Product Benchmarking
List of Figures
Figure 1 Female Health Tech Market Segmentation
Figure 2 Female Health Tech Market by Product: Market Attractiveness Index
Figure 3 Female Health Tech Market by Application: Market Attractiveness Index
Figure 4 Female Health Tech Market Attractiveness Index by Region
Figure 5 Female Health Tech Market: Market Dynamics
Figure 6 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 7 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 8 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 9 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 10 Female Health Tech Market: Porter’s Five Forces Analysis
Figure 11 Female Health Tech Market: PEST Analysis
Figure 12 Female Health Tech Market by Product Types: Market Attractiveness Index
Figure 13 Female Health Tech Market Forecast by Product Types, 2024-2034 (US$ Billion, AGR %)
Figure 14 Female Health Tech Market Share Forecast by Product Types, 2024, 2029, 2034 (%)
Figure 15 Consumer Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 16 Consumer Products Segment Market Share Forecast by Region, 2024 & 2034 (%)
Figure 17 Devices (Wearables, hardware) Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 18 Devices (Wearables, hardware) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 19 Software (Apps) Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 20 Software (Apps) Market Share Forecast by Region, 2024 & 2034 (%)
Figure 21 Diagnostics Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 22 Diagnostics Market Share Forecast by Region, 2024 & 2034 (%)
Figure 23 Digital Platform Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 24 Digital Platform Market Share Forecast by Region, 2024 & 2034 (%)
Figure 25 Drugs, Vitamins & Supplements Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 26 Drugs, Vitamins & Supplements Market Share Forecast by Region, 2024 & 2034 (%)
Figure 27 Services Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 28 Services Market Share Forecast by Region, 2024 & 2034 (%)
Figure 29 Telehealth Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 30 Telehealth Market Share Forecast by Region, 2024 & 2034 (%)
Figure 31 Female Health Tech Market by Application: Market Attractiveness Index
Figure 32 Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 33 Female Health Tech Market Share Forecast by Application, 2024, 2029, 2034 (%)
Figure 34 Pregnancy and Nursing Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 35 Pregnancy and Nursing Care Market Share Forecast by Region, 2024 & 2034 (%)
Figure 36 Reproductive Health and Contraception Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 37 Reproductive Health and Contraception Market Share Forecast by Region, 2024 & 2034 (%)
Figure 38 Menstrual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 39 Menstrual Health Market Share Forecast by Region, 2024 & 2034 (%)
Figure 40 General Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 41 General Healthcare Market Share Forecast by Region, 2024 & 2034 (%)
Figure 42 Pelvic and Uterine Healthcare Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 43 Pelvic and Uterine Healthcare Market Share Forecast by Region, 2024 & 2034 (%)
Figure 44 Sexual Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 45 Sexual Health Market Share Forecast by Region, 2024 & 2034 (%)
Figure 46 Women’s Wellness Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 47 Women’s Wellness Market Share Forecast by Region, 2024 & 2034 (%)
Figure 48 Menopause Care Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 49 Menopause Care Market Share Forecast by Region, 2024 & 2034 (%)
Figure 50 Longevity Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 51 Longevity Market Share Forecast by Region, 2024 & 2034 (%)
Figure 52 Mental Health Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
Figure 53 Mental Health Market Share Forecast by Region, 2024 & 2034 (%)
Figure 54 Female Health Tech Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
Figure 55 Female Health Tech Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 56 Female Health Tech Market by Region, 2024-2034 (US$ Billion, AGR %)
Figure 57 North America Female Health Tech Market Attractiveness Index
Figure 58 North America Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 59 North America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 60 North America Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 61 North America Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 62 North America Female Health Tech Market Share Forecast by Type, 2024 & 2034 (%)
Figure 63 North America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 64 North America Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 65 U.S. Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 66 Canada Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 67 Europe Female Health Tech Market Attractiveness Index
Figure 68 Europe Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 69 Europe Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 70 Europe Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 71 Europe Female Health Tech Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 72 Europe Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 73 Europe Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 74 Europe Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 75 Germany Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 76 France Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 77 UK Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 78 Italy Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 79 Spain Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 80 Russia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 81 Poland Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 82 Belgium Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 83 Rest of Europe Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 84 Asia Pacific Female Health Tech Market Attractiveness Index
Figure 85 Asia Pacific Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 86 Asia Pacific Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 87 Asia Pacific Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 88 Asia Pacific Female Health Tech Market Forecast by Product Type, 2024-2034 (US$ Billion, AGR %)
Figure 89 Asia Pacific Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 90 Asia Pacific Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 91 Asia Pacific Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 92 Japan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 93 China Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 94 India Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 95 Australia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 96 South Korea Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 97 Singapore Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 98 Taiwan Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 99 Rest of Asia Pacific Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 100 Latin America Female Health Tech Market Attractiveness Index
Figure 101 Latin America Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 102 Latin America Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 103 Latin America Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 104 Latin America Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 105 Latin America Female Health Tech Market Share Forecast by Type, 2024 & 2034 (%)
Figure 106 Latin America Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 107 Latin America Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 108 Brazil Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 109 Mexico Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 110 Argentina Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 111 Colombia Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 112 Rest of Latin America Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 113 MEA Female Health Tech Market Attractiveness Index
Figure 114 MEA Female Health Tech Market by Region, 2024, 2029 & 2034 (US$ Billion)
Figure 115 MEA Female Health Tech Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
Figure 116 MEA Female Health Tech Market Share Forecast by Country, 2024 & 2034 (%)
Figure 117 MEA Female Health Tech Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
Figure 118 MEA Female Health Tech Market Share Forecast by Product Type, 2024 & 2034 (%)
Figure 119 MEA Female Health Tech Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
Figure 120 MEA Female Health Tech Market Share Forecast by Application, 2024 & 2034 (%)
Figure 121 GCC Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 122 South Africa Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 123 Rest of MEA Female Health Tech Market Forecast, 2024-2034 (US$ Billion, AGR %)
Figure 124 Female Health Tech Company Share, 2022
Figure 125 HeraMed Ltd.: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 126 HeraMed Ltd.: R&D, 2017-2022 (US$ Million, AGR%)
Figure 127 Minerva Surgical, Inc.: Net Revenue, 2017-2023 (US$ Million, AGR%)
Figure 128 Minerva Surgical, Inc.: R&D, 2020-2022 (US$ Million, AGR%)
Figure 129 Sera Prognostics: Net Revenue, 2017-2022 (US$ Million, AGR%)
Figure 130 Sera Prognostics: R&D, 2017-2022 (US$ Million, AGR%)
ページTOPに戻る
本レポートと同じKEY WORD（covid19）の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
